达必妥治疗中重度特应性皮炎伴斑秃患者 1 例并文献复习
Improvement of alopecia areata with Dupilumab in a patient with severe atopic dermatitis and review the literature.
机构信息
Department of Dermatology, Hospital General Universitario de Valencia, Valencia, Spain.
出版信息
Australas J Dermatol. 2020 May;61(2):e223-e225. doi: 10.1111/ajd.13208. Epub 2019 Nov 25.
PMID:31766073
Abstract
Dupilumab, a biologic drug approved for the treatment of moderate-to-severe atopic dermatitis, has been associated with resolution or improvement in pre-existing alopecia areata. We report a case of significant improvement of AA after Dupilumab-onset treatment for atopic dermatitis and review the literature.
摘要
度普利尤单抗是一种获批用于治疗中重度特应性皮炎的生物制剂，与原有斑秃的缓解或改善相关。我们报告了一例特应性皮炎使用度普利尤单抗治疗后出现斑秃显著改善的病例，并复习了相关文献。
Zotero 插件